Novartis AGNVSNYSE
Loading
Operating Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+19.4%
5Y CAGR+8.9%
Studio
Year-over-Year Change

Operating income as a percentage of revenue

3Y CAGR
+19.4%/yr
vs +0.1%/yr prior
5Y CAGR
+8.9%/yr
Recent acceleration
Acceleration
+19.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
202531.15%+10.8%
202428.12%+34.3%
202320.94%+14.5%
202218.28%-20.0%
202122.87%+12.4%
202020.35%+9.0%
201918.67%+2.4%
201818.23%-9.1%
201720.05%+19.9%
201616.72%-